Search research articles
Contact Us
Filters
Showing results (71-80 of 142) with videos related to
Page
of 15
Sort By:
Brain Research
|
July 5, 1990
Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
J P O'Callaghan, D B Miller, J F Reinhard
Neuroscience
|
July 1, 1988
Trimethyltin-induced neuronal damage in the rat brain: comparative studies using silver degeneration stains, immunocytochemistry and immunoassay for neuronotypic and gliotypic proteins
C D Balaban, J P O'Callaghan, M L Billingsley
Neuroscience Letters
|
December 19, 1988
The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury
J F Reinhard, D B Miller, J P O'Callaghan
Synapse (New York, N.Y.)
|
April 1, 1997
Sequelae of parenteral domoic acid administration in rats: comparison of effects on different anatomical markers in brain
N M Appel, S I Rapoport, J P O'Callaghan
Brain Research
|
August 7, 1989
Glucocorticoids regulate the concentration of glial fibrillary acidic protein throughout the brain
J P O'Callaghan, R E Brinton, B S McEwen
Journal of Neurochemistry
|
September 1, 1991
Glucocorticoids regulate the synthesis of glial fibrillary acidic protein in intact and adrenalectomized rats but do not affect its expression following brain injury
J P O'Callaghan, R E Brinton, B S McEwen
Addiction Biology
|
June 26, 2010
Prior exposure to a behaviorally sensitizing regimen of d-methamphetamine does not alter the striatal dopaminergic damage induced by a neurotoxic regimen
D B Miller, J P O'Callaghan, E A Johnson
Addiction Biology
|
June 26, 2010
Chronic dopaminergic signaling in the basal ganglia: a damage perspective on kinases and fos-related antigens
J P O'Callaghan, D B Miller, K R Pennypacker
Analytical Biochemistry
|
October 21, 1999
Quantitative immunoblots of proteins resolved from brain homogenates: underestimation of specific protein concentration and of treatment effects
J P O'Callaghan, H Imai, D B Miller, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1979
The effects of opiates on the levels of cyclic 3':5'-guanosine monophosphate in discrete areas of the rat central nervous system
J P O'Callaghan, Q Chess, C McKimmey, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 142) with videos related to
Sort By:
Page
of 15
Brain Research
|
July 5, 1990
Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
J P O'Callaghan, D B Miller, J F Reinhard
Neuroscience
|
July 1, 1988
Trimethyltin-induced neuronal damage in the rat brain: comparative studies using silver degeneration stains, immunocytochemistry and immunoassay for neuronotypic and gliotypic proteins
C D Balaban, J P O'Callaghan, M L Billingsley
Neuroscience Letters
|
December 19, 1988
The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury
J F Reinhard, D B Miller, J P O'Callaghan
Synapse (New York, N.Y.)
|
April 1, 1997
Sequelae of parenteral domoic acid administration in rats: comparison of effects on different anatomical markers in brain
N M Appel, S I Rapoport, J P O'Callaghan
Brain Research
|
August 7, 1989
Glucocorticoids regulate the concentration of glial fibrillary acidic protein throughout the brain
J P O'Callaghan, R E Brinton, B S McEwen
Journal of Neurochemistry
|
September 1, 1991
Glucocorticoids regulate the synthesis of glial fibrillary acidic protein in intact and adrenalectomized rats but do not affect its expression following brain injury
J P O'Callaghan, R E Brinton, B S McEwen
Addiction Biology
|
June 26, 2010
Prior exposure to a behaviorally sensitizing regimen of d-methamphetamine does not alter the striatal dopaminergic damage induced by a neurotoxic regimen
D B Miller, J P O'Callaghan, E A Johnson
Addiction Biology
|
June 26, 2010
Chronic dopaminergic signaling in the basal ganglia: a damage perspective on kinases and fos-related antigens
J P O'Callaghan, D B Miller, K R Pennypacker
Analytical Biochemistry
|
October 21, 1999
Quantitative immunoblots of proteins resolved from brain homogenates: underestimation of specific protein concentration and of treatment effects
J P O'Callaghan, H Imai, D B Miller, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1979
The effects of opiates on the levels of cyclic 3':5'-guanosine monophosphate in discrete areas of the rat central nervous system
J P O'Callaghan, Q Chess, C McKimmey, et al.
Page
of 15